Valuation: Guided Therapeutics Inc

Market Cap 24.13M 20.67M 19.34M 17.68M 33.38M 2.3B 33.69M 228M 88.87M 1.16B 90.61M 88.64M 3.84B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 27.01M 23.13M 21.64M 19.79M 37.36M 2.58B 37.71M 255M 99.46M 1.3B 101M 99.2M 4.3B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%+7.28%+25.63%+16.75% 232B
+0.40%+6.58%+1.97%-14.82% 151B
-0.46%-4.74%-21.91%+30.18% 132B
+1.73%-3.05%-53.04%-1.13% 71.03B
-1.71%+1.79%-17.26%-13.17% 52.46B
+0.41%+0.07%+11.05%+21.14% 52.16B
+0.87%+4.26%+27.25%+29.53% 43.33B
+0.90%+1.64%+37.15%+52.83% 40.36B
-0.38%+2.13%-1.74%+8.01% 33.51B
Average -0.00%+1.82%+1.01%+14.37% 89.84B
Weighted average by Cap. -0.03%+2.78%+2.34%+11.93%

Financials

2024 2025
Net sales 7K 6K 5.61K 5.13K 9.68K 668K 9.77K 66.16K 25.78K 336K 26.28K 25.71K 1.11M 767K 657K 615K 562K 1.06M 73.17M 1.07M 7.25M 2.82M 36.87M 2.88M 2.82M 122M
Net income -2.42M -2.07M -1.94M -1.77M -3.34M -231M -3.37M -22.84M -8.9M -116M -9.07M -8.88M -385M -3.2M -2.74M -2.56M -2.34M -4.42M -305M -4.46M -30.21M -11.77M -154M -12M -11.74M -509M
Net Debt 1.77M 1.52M 1.42M 1.3M 2.45M 169M 2.47M 16.74M 6.52M 85.12M 6.65M 6.5M 282M 2.88M 2.46M 2.3M 2.11M 3.98M 274M 4.01M 27.18M 10.59M 138M 10.8M 10.56M 458M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-